e-learning
resources
Stockholm 2007
Wednesday 19.09.2007
The air we breathe at home and at work
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relationship between progression of disease on longitudinal high-resolution CT scans and progression of functional impairment in asbestosis
C. R. Nogueira, E. Bagatin, M. Terra-Filho, R. Tavares, L. M. Napolis, C. I. Silva, N. L. Muller, J. A. Neder, L. E. Nery (São Paulo, Campinas, Sao Paulo, Brazil; British Columbia, BC, Canada)
Source:
Annual Congress 2007 - The air we breathe at home and at work
Session:
The air we breathe at home and at work
Session type:
Oral Presentation
Number:
4441
Disease area:
Airway diseases, Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. R. Nogueira, E. Bagatin, M. Terra-Filho, R. Tavares, L. M. Napolis, C. I. Silva, N. L. Muller, J. A. Neder, L. E. Nery (São Paulo, Campinas, Sao Paulo, Brazil; British Columbia, BC, Canada). Relationship between progression of disease on longitudinal high-resolution CT scans and progression of functional impairment in asbestosis. Eur Respir J 2007; 30: Suppl. 51, 4441
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Asbestos related parenchymal and pleural disease: dissociation between rate of progression on high-resolution CT and functional impairment
Source: Eur Respir J 2006; 28: Suppl. 50, 693s
Year: 2006
Quantitative CT for the assessment of disease severity in interstitial lung disease
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020
Correlation of high resolution computed tomography (HRCT) findings with disease severity in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema
Year: 2007
Factors influencing the decline in lung density in a Danish lung cancer screening cohort
Source: Eur Respir J 2012; 40: 1142-1148
Year: 2012
High-resolution CT (HRCT) reflects disease progression in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
HRCT in the diagnosis of diffuse lung disease - overlap issues
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Tomographic pattern and disease progress or mortality in familial pulmonary fibrosis
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
CT safety issues
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Male gender and fibrosis score on high-resolution computed tomography are independent poor prognostic factors of survival in patients with rheumatoid arthritis-related interstitial lung disease.
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020
Thoracic high resolution computed tomography may be helpful in the differentiation between the patients with chronic obstructive pulmonary disease and the smoking patients with asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Longitudinal changes in structural abnormalities using MDCT in chronic obstructive pulmonary disease
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
The extent of emphysema in patients with COPD
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
Prevalence and clinical correlates of bronchoreversibility in severe emphysema
Source: Eur Respir J 2010; 35: 1048-1056
Year: 2010
Comparison of high resolution computer tomography (HRCT) findings in COPD patients between acute exacerbation and stable disease
Source: Annual Congress 2003 - Clinical and experimental thoracic imaging
Year: 2003
Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers
Source: Eur Respir J 2009; 33: 536-542
Year: 2009
High-resolution computed tomography scanning in α1-antitrypsin deficiency: relationship to lung function and health status
Source: Eur Respir J 2001; 17: 1097-1104
Year: 2001
Longitudinal serological assessment of neutrophil activity is related to disease progression in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept